Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 23:16:1662247.
doi: 10.3389/fendo.2025.1662247. eCollection 2025.

Editorial: Functional neuroendocrine tumors

Bojana Popovic  1   2 , Francesca Spada  3 , Aviral Singh  4   5 , Karin Zibar Tomsic  6
Affiliations
Editorial

Editorial: Functional neuroendocrine tumors

Bojana Popovic et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: advances in diagnosis and therapy; functional NET; hormonal secretory syndrome; neuroendocrine tumor; rare tumors.

PubMed Disclaimer

Conflict of interest statement

Author AS was employed by the company GenesisCare Australia Pty Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Functional neuroendocrine tumors

Similar articles

See all similar articles

References

    1. Daskalakis K. Functioning and nonfunctioning pNENs. Curr Opin Endocr Metab Res. (2021) 18:284–90. doi: 10.1016/j.coemr.2021.04.007 - DOI
    1. Spada F, Rossi RE, Modica R, Gelsomino F, Rinzivillo M, Rubino M, et al. Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist. Cancer Treat Rev. (2025) 135:102907. doi: 10.1016/j.ctrv.2025.102907, PMID: - DOI - PubMed
    1. Mitok KA, Keller MP, Attie AD. Sorting through the extensive and confusing roles of sortilin in metabolic disease. J Lipid Res. (2022) 63:100243. doi: 10.1016/j.jlr.2022.100243, PMID: - DOI - PMC - PubMed
    1. Kim JT, Napier DL, Weiss HL, Lee EY, Townsend CM, Evers BM. Neurotensin receptor 3/sortilin contributes to tumorigenesis of neuroendocrine tumors through augmentation of cell adhesion and migration. Neoplasia (United States). (2018) 20:175–81. doi: 10.1016/j.neo.2017.11.012, PMID: - DOI - PMC - PubMed
    1. Hofland LJ. Somatostatin and somatostatin receptors in Cushing’s disease. Mol Cell Endocrinol. (2008) 286:199–205. doi: 10.1016/j.mce.2007.10.015, PMID: - DOI - PubMed

Publication types

LinkOut - more resources